Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 14/20 | 0.59 |
| ▸ | MME | P08473 | 10/20 | 0.59 |
| ▸ | CPA1 | P15085 | 10/20 | 0.59 |
| ▸ | ACE2 | Q9BYF1 | 10/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30411925 | 0.86 | LMNA (0.50) | ACEMMECPA1ACE2LMNA | |
| SCHEMBL29601051 | 0.83 | LMNA (0.52) | ACEMMECPA1ACE2LMNA | |
| SCHEMBL157547 | 0.82 | MME (0.61) | ACEMMECPA1ACE2 | |
| SCHEMBL8823249 | 0.81 | MME (0.54) | ACEMMECPA1ACE2LMNA | |
| SCHEMBL2780445 | 0.81 | LMNA (0.54) | ACEMMECPA1ACE2LMNA | |
| SCHEMBL2780446 | 0.81 | LMNA (0.54) | ACEMMECPA1ACE2LMNA | |
| SCHEMBL25284015 | 0.78 | MME (0.62) | ACEMMECPA1ACE2LMNA | |
| SCHEMBL28286750 | 0.78 | MME (0.62) | ACEMMECPA1ACE2LMNA | |
| SCHEMBL15692294 | 0.78 | MME (0.57) | ACEMMECPA1ACE2 | |
| SCHEMBL15692326 | 0.78 | ACE (0.68) | ACEMMECPA1ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024195825-A1 | CEREBRAL ATROPHY ASSESSMENT METHOD USING BLOOD METABOLOME | 味の素株式会社 | 2024-09-26 | — | — | WO | disclosed |
| WO-2023130538-A1 | TRACE SAMPLE-BASED METHOD FOR HIGH-THROUGHPUT RECOGNITION OF TRACE ORGANIC POLLUTANTS IN BLOOD | 南京大学 | 2023-07-13 | — | — | WO | disclosed |